Results 301 to 310 of about 361,742 (335)

Brain metastases from epithelial ovarian carcinoma

International Journal of Gynecological Cancer, 2000
BACKGROUND: Brain metastases from epithelial ovarian carcinoma are rare. We reviewed our experience to evaluate the results of different treatments and their prognosis. Discussion is based on a review of the literature. METHODS: From 1974 to 1998, eight of 704 patients treated for epithelial ovarian carcinoma at our large cancer center developed brain ...
M.-C., Kaminsky-Forrett, B., Weber, T., Conroy, D., Spaëth   +3 more
openaire   +2 more sources

Cytogenetic studies of epithelial ovarian carcinoma

Cancer Genetics and Cytogenetics, 1993
We performed cytogenetic studies of 36 human epithelial ovarian carcinomas using in situ culture and robotic harvest. We obtained analyzable metaphases of all 36 tumors (100%). One or more chromosomally abnormal clones were observed in 80% of tumors. Common clonal chromosome gains (each occurring in six or more cases) included +1, +2, +3, +6, +7, +9 ...
R B, Jenkins, D, Bartelt, P, Stalboerger, D, Persons, R J, Dahl, K, Podratz, G, Keeney, L, Hartmann   +7 more
openaire   +2 more sources

Mucinous Ovarian Carcinoma.

New England Journal of Medicine, 2019
Mucinous Ovarian Cancer Mucinous ovarian cancer accounts for 3% of epithelial ovarian cancers and must be distinguished from mucinous carcinomas that have metastasized to the ovary.
P. Morice, S. Gouy, A. Leary
semanticscholar   +1 more source

Modern treatment options in epithelial ovarian carcinoma

Current Opinion in Obstetrics and Gynaecology, 1998
Treatment options for epithelial ovarian cancers are under constant evolution. Recent advances have occurred in both first-line and second-line chemotherapeutic regimens. A newly published approach to first-line therapy incorporating intraperitoneal chemotherapy has demonstrated a benefit in selected patients.
I, Benjamin, S C, Rubin
openaire   +2 more sources

Staging laparotomy in early epithelial ovarian carcinoma

American Journal of Obstetrics and Gynecology, 1986
It is well known that ovarian carcinoma may have subclinically metastasized at the time of the initial surgical operation when all tumor seemed to be confined to the ovary. A retrospective review of 650 ovarian carcinoma patients from 1976 to 1984 revealed 25 staging laparotomies for early epithelial ovarian carcinoma.
M E, Helewa, G V, Krepart, R, Lotocki
openaire   +2 more sources

Management of recurrent epithelial ovarian carcinoma

Australian and New Zealand Journal of Obstetrics and Gynaecology, 2005
AbstractDespite the standardisation of surgical techniques and significant progress in chemotherapeutics over the last 30 years, advanced epithelial ovarian cancer remains the most lethal gynaecological malignancy in the western world. Although the majority of women achieve a remission following primary therapy, most patients with advanced stage ...
openaire   +3 more sources

Tissue immune response in epithelial ovarian carcinoma.

Journal of Clinical Oncology, 2019
2625 Background: Epithelial ovarian cancer (EOC) is a highly malignant disease with a fatal outcome for most patients. During recent years immunological mechanisms have proven important in relation to the treatment and prognosis of cancer, but within EOC the knowledge is still sparse. Understanding the importance of immune markers to the prognosis of
Henriksen, Jon, Donskov, Frede, Waldstrom, Marianne, Hjortkjaer, Mette, Petersen, Christina Braad, Thomsen, Caroline Brenner, Jakobsen, Anders Kristian Moeller, Steffensen, Karina Dahl   +7 more
openaire   +2 more sources

Ovarian epithelial carcinoma with estrogen‐producing stroma

Pathology International, 2007
Malignant ovarian neoplasms derived from ovarian epithelium that produce estrogen are rare among postmenopausal women. Presented herein is a case of stage Ic(a) endometrioid adenocarcinoma in the right ovary of an 81‐year‐old woman, who complained of mammary tenderness, pain and atypical genital bleeding.
Hideki, Tokunaga, Jun-ichi, Akahira, Takashi, Suzuki, Takuya, Moriya, Hironobu, Sasano, Kiyoshi, Ito, Nobuo, Yaegashi   +6 more
openaire   +2 more sources

Epithelial ovarian carcinoma of low malignant potential

European Journal of Obstetrics & Gynecology and Reproductive Biology, 1996
The aim of this study was to evaluate the interest of sonographic features, serum marker tumors and conservative treatment especially by laparoscopic approach of epithelial ovarian tumors of low malignant potential (or borderline tumors).Thirty-four patients with 40 epithelial ovarian tumors of low malignant potential treated at Bichat Claude Bernard ...
E, Darai, J, Teboul, F, Walker, J L, Benifla, E, Meneux, J N, Guglielmina, G, Pennehouat, C, Renolleau, E, Sebban, P, Madelenat   +9 more
openaire   +2 more sources

Tamoxifen therapy in recurrent epithelial ovarian carcinoma

Gynecologic Oncology, 1987
Thirty-seven patients with recurrent epithelial ovarian carcinoma were entered into a trial of tamoxifen therapy (10 mg BID) to determine the effect on long-term survival. Thirty-one patients were evaluable with follow-up ranging from 6 to 42 months since initiation of hormonal therapy.
S A, Weiner, D S, Alberts, E A, Surwit, J, Davis, D, Grosso   +4 more
openaire   +2 more sources